Curr Opin Lipidol. 1994 Oct;5(5):339-49.

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.

Source

Life Sciences Division, Lawrence Berkeley Laboratory, University of California, Berkeley.

Abstract

Increased levels of IDL and small, dense LDL are associated with the risk of coronary artery disease. Possible mechanisms include increased susceptibility of small, dense LDL to oxidation, and to other pathologic effects, such as increased retention in the arterial wall. Beneficial effects of a low-fat diet and certain lipid-lowering therapies on the levels and properties of small, dense LDL or their precursors may contribute substantially to the reductions in coronary atherosclerosis observed in several lipid-lowering trials.

PMID:: 7858908; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Ovid Technologies, Inc.

Supplemental Content

Related citations

Review Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. [Eur Heart J. 1998]
Review Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman MJ, Guérin M, Bruckert E. Eur Heart J. 1998 Feb; 19 Suppl A:A24-30.
Review [Atherogenicity of low-density lipoproteins (LDL). A problem of quantity or quality?]. [Presse Med. 1995]
Review [Atherogenicity of low-density lipoproteins (LDL). A problem of quantity or quality?].
Dejager S, Turpin G. Presse Med. 1995 Dec 9; 24(38):1772-6.
The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status. [Coron Artery Dis. 2002]
The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status.
Orem C, Orem A, Uydu HA, Celik S, Erdöl C, Kural BV. Coron Artery Dis. 2002 Feb; 13(1):65-71.
Review Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. [Am J Cardiol. 2002]
Review Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
Kwiterovich PO Jr. Am J Cardiol. 2002 Oct 17; 90(8A):30i-47i.
Atherogenicity of triglyceride-rich lipoproteins. [Am J Cardiol. 1998]
Atherogenicity of triglyceride-rich lipoproteins.
Krauss RM. Am J Cardiol. 1998 Feb 26; 81(4A):13B-17B.

See reviews... See all...

Cited by 6 PubMed Central articles

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy. [Vasc Health Risk Manag. 2010]
Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy.
Insull W Jr, Toth PP, Superko HR, Thakkar RB, Krause S, Jiang P, Parreno RA, Padley RJ. Vasc Health Risk Manag. 2010 Nov 24; 6:1065-75. Epub 2010 Nov 24.
Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. [J Clin Lipidol. 2008]
Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.
Stein JH, Komarow L, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, et al. J Clin Lipidol. 2008 Dec; 2(6):464-471.
Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss. [Nutr Metab (Lond). 2006]
Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss.
Feinman RD, Volek JS. Nutr Metab (Lond). 2006 Jun 21; 3:24. Epub 2006 Jun 21.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.
Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.
Curr Opin Lipidol. 1994 Oct ;5(5):339-49.

PubMed
Influence of dietary menhaden oil upon carcinogenesis and various cutaneous resp...
Influence of dietary menhaden oil upon carcinogenesis and various cutaneous responses to ultraviolet radiation.
Photochem Photobiol. 1989 Jan ;49(1):71-7.

PubMed
Zinc absorption in humans from meals based on rye, barley, oatmeal, triticale an...
Zinc absorption in humans from meals based on rye, barley, oatmeal, triticale and whole wheat.
J Nutr. 1987 Nov ;117(11):1898-902.

PubMed
Polyphenols, astringency and proline-rich proteins.
Polyphenols, astringency and proline-rich proteins.
Phytochemistry. 1994 Sep ;37(2):357-71.

PubMed
Magnesium supplementation reduces development of diabetes in a rat model of spon...
Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM.
Am J Physiol. 1995 Oct ;269(4 Pt 1):E745-52.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Cited by 6 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information